Advisory Services Network’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Advisory Services Network’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-38	Closed	-$3K	–	2094
2016 Q2	$3K	Hold	38	–	–	﹤0.01%	1600
2016 Q1	$3K	Buy	+38	New	+$2.42K	﹤0.01%	1427

Other funds holding PLXP

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Advisory Services Network's PLXP Position: Q3 2016 in Review

Advisory Services Network sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2016, closing a stake of 38 shares — an estimated $3K sold.

Advisory Services Network first reported a position in PLXP in Q1 2016 and held it in 2 quarters. The position peaked at $3K in Q2 2016. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

Advisory Services Network reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Advisory Services Network sold 38 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $3K.
Advisory Services Network first reported a position in PLx Pharma Inc. Common Stock in Q1 2016 and held it in 2 quarters.
Advisory Services Network's PLx Pharma Inc. Common Stock position peaked at $3K in Q2 2016.
32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on Advisory Services Network's 13F filing for Q3 2016, filed 7 Oct 2016.